Medications affecting the insulin-like growth factor 1/growth hormone axis, including teprotumumab, somatostatin analogs, and anti-calcitonin gene-related peptide monoclonal antibodies, are associated with elevated reporting odds of alopecia in women: A pharmacovigilance study.
J Am Acad Dermatol
; 89(2): 408-410, 2023 08.
Article
en En
| MEDLINE
| ID: mdl-37062463
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Somatostatina
/
Péptido Relacionado con Gen de Calcitonina
Tipo de estudio:
Risk_factors_studies
Límite:
Female
/
Humans
Idioma:
En
Año:
2023
Tipo del documento:
Article